SeaBeLife
French tech company | Builders Republic
About
Drug-discovery biotech developing small molecules that block regulated cell death — protecting tissue from the necrosis pathways behind acute and chronic organ damage, with lead programs targeting dry age-related macular degeneration of the eye and severe acute hepatitis of the liver.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Venture Round
- Founded
- 2019
- City
- ROSCOFF
- Region
- Bretagne
- Tracked rounds
- 1
- Amount raised
- 2.0 M€ raised since 2020
Funding rounds
- Venture Round — 2025